Drugs Made In America Acquisition Corp. Ordinary Shares

NASDAQ:DMAA

Shell Companies

Financial Services
$10.90 +0.00%

+$0.00 today

Market cap
$264.62M
Beta
0.00
P/E (TTM)
36.7
EPS (TTM)
$0.29
52W Low $10.17High $10.63

Volume 0.00M

Average 0.11M

DMAA Common Stock Issued

Cash raised by issuing new shares.

Drugs Made In America Acquisition Corp. Ordinary SharesNASDAQ: DMAA

Common Stock Issued · Q1 FY2026 · quarter ended Mar 2026

Common stock issued outflow shrinks to $0

Q1 FY2026 common stock issued was $0, compared with $232.05M a year earlier. Trailing-twelve-month common stock issued was -$232.05M.

What to watch

Whether quarterly common stock issued holds near $0 or moves back toward the trailing-twelve-month quarterly average of -$58.01M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$232.05M+70718.0% YoY
LTMMar 2026
-$232.05M-200.2% YoY
Common Stock Issued past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-100.0%——
1 year+70718.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Common Stock Issued history

USD · from the cash flow

Latest · FY2025
232.05M USD
Year-over-year change
+70718.0%

Common Stock Issued vs competitors

How DMAA compares with its peers on the latest reported figures

  • DMAA's LTM Mar 2026 common stock issued of $232.05M is the 6th largest of the 10 companies compared; the peer median is $234.25M.
  • Its year-over-year change of -200.2% is the lowest of 2, against a peer median of -100.0%.
DMAA Competitors Peer median
Common Stock Issued for DMAA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TACOUBerto Acquisition Corp. UnitFY2025$303.65M ———
TACOBerto Acquisition Corp.FY2025$303.65M ———
TACHTitan Acquisition Corp.LTM Mar 2026$284.11M ———
OYSEOyster Enterprises II Acquisition CorpFY2025$255.02M ———
LOKVLive Oak Acquisition Corp. V Class A Ordinary SharesFY2025$234.25M ———
DMAADrugs Made In America Acquisition Corp. Ordinary SharesLTM Mar 2026$232.05M -200.2%——
RTACRenatus Tactical Acquisition Corp I Class A Ordinary SharesLTM Mar 2026$275.09K ———
ALFCenturion Acquisition Corp.LTM Mar 2026$0 ———
SIMASIM Acquisition Corp. ILTM Mar 2026$0 ———
MLACMountain Lake Acquisition Corp.FY2025$0 -100.0%——
Peer median (excluding DMAA) $234.25M-100.0%——

Competitors are the stored peer set for DMAA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Drugs Made In America Acquisition Corp. Ordinary Shares

NASDAQ:DMAA

Intrinsic Alpha fair value

Locked

Current Price

$10.90

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.